Assuming patients is required, the following results were found.

  • Novartis receives positive CHMP opinion for Mayzent® (siponimod) for the treatment of adult patients with active secondary progressive multiple sclerosis (SPMS) | Small Molecules | News Channels - PipelineReview.com

    Novartis receives positive CHMP opinion for Mayzent® (siponimod) for the treatment of adult patients with active secondary progressive multiple sclerosis (SPMS) DetailsHits: 158If approved, Mayzent® (siponimod) will be the first and only oral treatment...

    https://mschristian.org/index.php/component/easyblog/novartis-receives-positive-chmp-opinion-for-mayzent-siponimod-for-the-treatment-of-adult-patients-with-active-secondary-progressive-multiple-sclerosis-spms-small-molecules-news-channels-pipelinereview-com?Itemid=341
  • Novartis receives positive CHMP opinion for Mayzent® (siponimod) for the treatment of adult patients with active secondary progressive multiple sclerosis (SPMS) | Small Molecules | News Channels - PipelineReview.com

    Novartis receives positive CHMP opinion for Mayzent® (siponimod) for the treatment of adult patients with active secondary progressive multiple sclerosis (SPMS) Details Hits: 158 If approved, Mayzent® (siponimod) will be the first and only oral...

    https://mschristian.org/index.php/articles/2-uncategorised/9270-novartis-receives-positive-chmp-opinion-for-mayzent-siponimod-for-the-treatment-of-adult-patients-with-active-secondary-progressive-multiple-sclerosis-spms-small-molecules-news-channels-pipelinereview-com
  • "Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction"

    and immunopathogenesis and instead share some clinical pearls to help both simplify and advance your care for patients and families affected by MS. My goal is to share a simple approach that will serve you and your patients well, with the aim of helping...

    https://mschristian.org/index.php/component/easyblog/treating-ms-a-simplified-strategy-boosts-patient-and-provider-satisfaction?Itemid=341
  • DOUBT Study Clarifies Role of MRI for TIA or Stroke

    (MRI). Question Addressed: What was the rate of stroke defined by diffusion restriction detected on MRI scans among patients with low-risk suspected transient ischemic attack (TIA) or minor stroke presentations? Study Synopsis and Perspective: Patients...

    https://mschristian.org/index.php/component/easyblog/doubt-study-clarifies-role-of-mri-for-tia-or-stroke?Itemid=341
  • Demyelinating Risks With Anti-TNF Vary in Rheumatic Diseases - MedPage Today

    Patients with certain types of arthritic conditions were at elevated risk for developing neuroinflammatory events if treated with tumor necrosis factor (TNF) inhibitors, a large prospective cohort study conducted in Denmark and Sweden found. Among...

    https://mschristian.org/index.php/component/easyblog/demyelinating-risks-with-anti-tnf-vary-in-rheumatic-diseases-medpage-today?Itemid=341
  • DOUBT Study Clarifies Role of MRI for TIA or Stroke

    (MRI). Question Addressed: What was the rate of stroke defined by diffusion restriction detected on MRI scans among patients with low-risk suspected transient ischemic attack (TIA) or minor stroke presentations? Study Synopsis and Perspective: Patients...

    https://mschristian.org/index.php/articles/2-uncategorised/8834-doubt-study-clarifies-role-of-mri-for-tia-or-stroke
  • First Report of COVID-19 Neurologic Symptoms in China

    symptoms, researchers said. Acute cerebrovascular events, impaired consciousness, and muscle injury were seen in 36.4% of patients and were more common (45.5%) in patients with severe infection who required mechanical ventilation, reported Bo Hu, MD,...

    https://mschristian.org/index.php/component/easyblog/first-report-of-covid-19-neurologic-symptoms-in-china?Itemid=341
  • Atara Biotherapeutics Announces Third Quarter 2019 Financial Results and Recent Clinical, Operational and Strategic Progress - BioSpace

    Inc., (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today reported financial results for the third quarter of 2019 and recent...

    https://mschristian.org/index.php/component/easyblog/atara-biotherapeutics-announces-third-quarter-2019-financial-results-and-recent-clinical-operational-and-strategic-progress-biospace?Itemid=341
  • Most Hospitalized COVID Patients Have Neurologic Symptoms

    More than half of COVID-19 patients admitted to two hospitals in Spain developed some form of neurologic symptoms, a retrospective, observational study showed. Neurologic manifestations were seen in 57.4% of 841 patients hospitalized with COVID-19 in...

    https://mschristian.org/index.php/articles/2-uncategorised/10852-most-hospitalized-covid-patients-have-neurologic-symptoms
  • First Report of COVID-19 Neurologic Symptoms in China

    symptoms, researchers said. Acute cerebrovascular events, impaired consciousness, and muscle injury were seen in 36.4% of patients and were more common (45.5%) in patients with severe infection who required mechanical ventilation, reported Bo Hu, MD,...

    https://mschristian.org/index.php/articles/2-uncategorised/10546-first-report-of-covid-19-neurologic-symptoms-in-china
  • Parasitic worms could offer new treatment hope for MS patients

    Reviewed by Emily Henderson, B.Sc.Jun 18 2020 Parasitic worms could offer a new treatment hope for patients suffering from the autoimmune disease multiple sclerosis, according to experts from the University of Nottingham. The findings of the research,...

    https://mschristian.org/index.php/articles/2-uncategorised/10898-parasitic-worms-could-offer-new-treatment-hope-for-ms-patients
  • Atara Biotherapeutics Announces Third Quarter 2019 Financial Results and Recent Clinical, Operational and Strategic Progress - BioSpace

    Inc., (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today reported financial results for the third quarter of 2019 and recent...

    https://mschristian.org/index.php/articles/2-uncategorised/9192-atara-biotherapeutics-announces-third-quarter-2019-financial-results-and-recent-clinical-operational-and-strategic-progress-biospace
  • Hookworm trial offers new hope to MS patients

    Parasitic worms could offer a new treatment hope for patients suffering from the autoimmune disease multiple sclerosis, according to experts from the University of Nottingham. The findings of the research, published in the journal JAMA Neurology, show...

    https://mschristian.org/index.php/articles/2-uncategorised/10901-hookworm-trial-offers-new-hope-to-ms-patients
  • Most Hospitalized COVID Patients Have Neurologic Symptoms

    More than half of COVID-19 patients admitted to two hospitals in Spain developed some form of neurologic symptoms, a retrospective, observational study showed. Neurologic manifestations were seen in 57.4% of 841 patients hospitalized with COVID-19 in...

    https://mschristian.org/index.php/component/easyblog/most-hospitalized-covid-patients-have-neurologic-symptoms?Itemid=101
  • Short-Duration Opioid Protocol Feasible for Tonsillectomy

    within the first year after surgery, a retrospective analysis of active-duty military personnel showed. Of almost 700 patients who received as much as a 15-day postoperative prescription of opioid-containing medication, none had a referral for treatment...

    https://mschristian.org/index.php/component/easyblog/short-duration-opioid-protocol-feasible-for-tonsillectomy?Itemid=341
  • Rethinking neurodegenerative disease treatment: Target multiple pathological proteins

    all of the different neurodegenerative disorders and may instigate each other to drive disease severity in many aging patients. The prevalence of these co-pathologies suggests that each disease may ultimately require combination therapy targeting...

    https://mschristian.org/index.php/component/easyblog/rethinking-neurodegenerative-disease-treatment-target-multiple-pathological-proteins?Itemid=341
  • COVID-19 and Neuromyelitis Optica Disorder: A Need for Guidance-Based Management - Neurology Advisor

    disease 2019 (COVID-19) pandemic continues to unfold and healthcare workers scramble to meet demands of affected patients, little guidance has been issued on how to manage patients with COVID-19 and coexisting neurological disorders. In a recent paper...

    https://mschristian.org/index.php/component/easyblog/covid-19-and-neuromyelitis-optica-disorder-a-need-for-guidance-based-management-neurology-advisor?Itemid=341
  • Coronavirus Outbreak: Daily Updates

    scientists are just beginning to understand the array of health problems caused by the coronavirus, which may affect both patients and health systems for some time. Texas Governor Greg Abbott announced that reopening will be paused as the state is...

    https://mschristian.org/index.php/articles/2-uncategorised/10909-coronavirus-outbreak-daily-updates
  • Antiviral cocktail may help treat mild COVID-19 patients

    Now, a team of researchers in Hong Kong suggests that combining three existing antivirals may help treat COVID-19 patients. The team has found that patients experiencing mild symptoms caused by the novel coronavirus recover faster if they are treated...

    https://mschristian.org/index.php/articles/2-uncategorised/10801-antiviral-cocktail-may-help-treat-mild-covid-19-patients
  • Coronavirus Outbreak: Daily Updates

    scientists are just beginning to understand the array of health problems caused by the coronavirus, which may affect both patients and health systems for some time. Texas Governor Greg Abbott announced that reopening will be paused as the state is...

    https://mschristian.org/index.php/component/easyblog/coronavirus-outbreak-daily-updates?Itemid=101

Results 1 - 20 of 578